PCRX Pacira BioSciences, Inc.
Price Chart
Executive Summary
Pacira BioSciences saw two insider sales totaling $372K over a week, including the Chief Administrative Officer and SVP of Finance. The total value is 0.04% of the $905M market cap, which is trivial. The cluster is dominated by non-cash director grants ($0 value) that carry no economic signal, making the selling activity routine and non-informative.
Key Financial Metrics
Actionable Insight
The insider sales are too small to signal any material concern. Monitor upcoming quarterly earnings for any guidance revision or pipeline update, as the stock's recent weakness (-2.25% avg T+20 return on prior reports) suggests broader headwinds.
Key Facts
- Two insiders sold shares: CAO Kristen Williams ($228K) and SVP Finance Lauren Riker ($144K), total $372K.
- Total selling value is 0.04% of $905M market cap — trivial and routine.
- 14 director grants (non-cash, $0 value) occurred on 2026-06-10, representing standard equity compensation, not a trading signal.
- Historical calibration shows past PCRX reports had a 33% win rate at T+20 with -2.25% average return, suggesting the stock has been weak regardless of filing content.
Financial Impact
Insider sales of $372K represent 0.04% of market cap — immaterial.
Risk Factors
- No material insider buying to offset the selling pattern.
- Stock has underperformed SPY by -7.46% alpha at T+20 on prior reports, indicating persistent negative sentiment.
Market Snapshot
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-PCRX-1781312904049 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 13, 2026
2d ago
|
Insider Cluster
| — | awaiting T+1 | — | — |
|
Jun 4, 2026
10d ago
|
DEFA14A
| $22.67 awaiting T+1 | awaiting T+1 | — | $22.99 (+1.41%) |
|
Jun 4, 2026
10d ago
|
144
| $22.67 $22.75 | ▲ +0.35% | ▲ +2.95% | $22.99 (+1.41%) |
|
Jun 1, 2026
13d ago
|
DEFA14A
| $22.25 $22.32 | ▲ +0.31% | ▲ +1.04% | $22.99 (+3.33%) |
|
May 27, 2026
18d ago
|
DEFA14A
| $23.68 $23.22 | ▼ −1.94% | ▼ −2.18% | $22.99 (−2.91%) |
|
May 26, 2026
19d ago
|
DEFA14A
| $24.04 $23.68 | ▼ −1.50% | ▼ −2.05% | $22.99 (−4.37%) |
|
May 20, 2026
25d ago
|
DEFA14A
| $23.48 $23.35 | ▼ −0.55% | ▼ −1.00% | $22.99 (−2.09%) |
|
May 20, 2026
25d ago
|
Press Release
| $23.00 $23.48 | ▲ +2.09% | ▲ +1.89% | $22.99 (−0.04%) |
|
Apr 30, 2026
6w ago
|
8-K
| $24.44 $24.69 | ▲ +1.02% | ▲ +1.36% | $22.99 (−5.93%) |
|
Apr 17, 2026
8w ago
|
PREC14A
| $24.90 $24.64 | ▼ −1.04% | ▼ −0.39% | $22.99 (−7.67%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access